ArticleFrontiers in cardiovascular medicine2026
Descriptive analysis of hypertension in Saudi Arabia: a national population health perspective (hypertension in Saudi Arabia).
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence of Risk Factors and Awareness of University Students regarding Hypertension and Cardiovascular Diseases in Riyadh, Saudi Arabia.Journal of community health · 2026Article
- Undiagnosed and Uncontrolled Hypertension in the Aseer Region, Saudi Arabia: A Ramadan Screening Study with Long-Term Trends (1990-2019) and Projections to 2027.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension (HTN) is one of the most significant public health challenges in Saudi Arabia, driven by ageing, lifestyle changes and rising metabolic risk factors. Although the prevalence of HTN is increasing in Saudi Arabia, there have been limited studies and updates of national-level numbers. Objective: This study provides a national-level descriptive overview of high blood pressure in Saudi Arabia using data from the Population Health Observatory (PHO). These data include prevalence, demographics and characteristics, comorbidities and risk and healthcare utilisation. Methods: A retrospective observational study using data from the PHO from 2015 to 2025 was conducted, including all 1.7 million diagnosed individuals across all regions of Saudi Arabia. Descriptive analyses were performed for the variables. Results: The analysis revealed 1,720,786 hypertensive patients in Saudi Arabia. The highest burden falls on males, accounting for 58.2% of hypertensive patients. Of those males, the majority were aged 50-59 years. Most patients were obese or overweight (29.4% and 21.8%, respectively). The majority of the patients had a rising risk profile, and most of them visited outpatient clinics (88.9%). Conclusion: HTN remains a major public health concern in Saudi Arabia. The data from the PHO highlighted clear results and patterns that can guide interventions and policymakers in strengthening prevention and improving health promotion and control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.